GP0525D MM patients treated with BLENREP in the US

We would like to invite you to take part in a new study for adults with multiple myeloma who have taken the medication, BLENREP. This research will explore your experience with Multiple Myeloma and BLENREP treatment. Your participation in this study will help patients and doctors know what to expect from the treatment. It may also help other patients with multiple myeloma treated with BLENREP in the future.

The study consists of a 90-minute telephone interview to be completed in 1 or 2 sessions (upon your preferences). Participants will receive 175USD as a token of appreciation for their time upon completion.

If interested, please contact us at

Join this Study
Are you already a member of Global Patients?